Mitochondrial dysfunction and apoptosis are attenuated through activation of AMPK/GSK-3β/PP2A pathway in Parkinson's disease-Reference-Cited by-同舟云学术

Mitochondrial dysfunction and apoptosis are attenuated through activation of AMPK/GSK-3β/PP2A pathway in Parkinson's disease

Published:2021-09 Issue: Volume:907 Page:174202
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Su Jianhua,Zhang Junhua,Bao Rui,Xia Changbo,Zhang Yu,Zhu Zhujun,Lv Qi,Qi Yingjie,Xue Jianqin

Publisher

Elsevier BV

Subject

Pharmacology

Reference38 articles.

1. Dysregulation of astrocytic mitochondrial function following exposure to a dopamine metabolite: implications for Parkinson's disease;Bagnoli;Eur. J. Neurosci.,2020

2. Ghrelin is neuroprotective in Parkinson's disease: molecular mechanisms of metabolic neuroprotection;Bayliss;Ther. Adv. Endocrinol. Metab.,2013

3. Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's disease;Braithwaite;Neurochem. Int.,2012

4. Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity;Bobela;Mol. Neurodegener.,2017

5. Dual effects of S-adenosyl-methyonine on PC12 cells exposed to the dopaminergic neurotoxin MPP;Cantelmo;J. Pharm. Pharmacol.,2020

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impacts of exposure to and subsequent discontinuation of clozapine on tripartite synaptic transmission;British Journal of Pharmacology;2024-08-02

2. Molecular Role of Protein Phosphatases in Alzheimer’s and Other Neurodegenerative Diseases;Biomedicines;2024-05-15

3. Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model;Neurochemical Research;2024-03-29

4. Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue;Molecular Neurobiology;2024-02-17

5. AMPK signaling pathway as a potential therapeutic target for Parkinson's disease;Advanced Pharmaceutical Bulletin;2023-10-14